MedTrace Logo

Magnetic Resonance Imaging of Calculus Problem Solving

NCT00060658 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2008-03-04

No results posted yet for this study

Summary

This study will use magnetic resonance imaging (MRI) to identify brain regions involved in solving algebraic math problems. It will examine brain activation according to the level of difficulty and the number of steps required to solve the problem. This information will help identify a possible correlation between problem-solving strategies and patterns of brain activation.

Undergraduate or graduate students between 19 and 36 years of age who have completed at least 2 years of college, have had at least one college course in integral calculus, and who have no history of neurological disease may be eligible for this study. Candidates will be screened with a medical history, including psychiatric and neurological information.

Participants will be asked to mentally solve a variety of integral calculus problems while undergoing MRI scanning, a procedure that uses a strong magnetic field and radio waves to produce images of structural and chemical changes in the brain. During the scan, the subject lies on a table in a narrow cylinder (the scanner) containing a magnetic field. A problem and possible solution are presented to the subject, who presses a button to verify if the answer is correct. At the end of the test, the participant completes a follow-up questionnaire to determine the problem-solving strategies used.

Conditions

  • Healthy

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    lead NIH

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-05-31
Completion
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00060658 on ClinicalTrials.gov